Bag This Deal Even Lower Than Director Juda Did
November 22, 2021 at 12:16 PM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 17, INmune Bio Inc's Director, Scott Juda, invested $33,875.00 into 2,500 shares of INMB, for a cost per share of $13.55..